We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$20.4M
Cap. Flow
+$12.4M
Cap. Flow %
8.35%
Top 10 Hldgs %
99.46%
Holding
12
New
1
Increased
4
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$6.38M
2
RXRX icon
Recursion Pharmaceuticals
RXRX
+$4M
3
OCS icon
Oculis Holding
OCS
+$2.23M
4
BIOA
BioAge Labs
BIOA
+$2.17M
5
ZBIO
Zenas BioPharma
ZBIO
+$1.34M

Top Sells

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$3.76M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$8.81B
$57.6M 38.91%
703,834
+64,295
+10% +$6.38M
OCS icon
2
Oculis Holding
OCS
$708M
$29.5M 19.95%
1,737,696
+141,778
+9% +$2.23M
ARQT icon
3
Arcutis Biotherapeutics
ARQT
$3.3B
$29.5M 19.95%
2,120,508
– –
INZY
4
DELISTED
Inozyme Pharma
INZY
$12.5M 8.41%
4,494,851
– –
ZBIO
5
Zenas BioPharma
ZBIO
$2.05B
$6.03M 4.07%
736,645
+85,950
+13% +$1.34M
RXRX icon
6
Recursion Pharmaceuticals
RXRX
$1.8B
$4.03M 2.72%
+595,518
New +$4M
BIOA
7
BioAge Labs
BIOA
$490M
$3.78M 2.56%
653,374
+125,727
+24% +$2.17M
RLYB icon
8
Rallybio
RLYB
$87M
$2.31M 1.56%
300,581
– –
BOLT icon
9
Bolt Biotherapeutics
BOLT
$7.65M
$1.02M 0.69%
94,573
– –
VIGL
10
DELISTED
Vigil Neuroscience
VIGL
$953K 0.64%
560,595
– –
IOBT
11
DELISTED
IO Biotech
IOBT
$795K 0.54%
864,197
– –
EXAI
12
DELISTED
Exscientia Plc American Depositary Shares
EXAI
– –
-770,500
Closed -$3.76M

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q4 2024 Portfolio in Review

As of Q4 2024, Pivotal bioVenture Partners Investment Advisor held 12 positions worth $148M, down 12% from $168M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Pivotal bioVenture Partners Investment Advisor deployed $12.4M of net new capital in Q4 2024, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Recursion Pharmaceuticals: 595,518 shares worth $4.03M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Exscientia Plc American Depositary Shares, an estimated $3.76M sold.

  • Pivotal bioVenture Partners Investment Advisor's largest Q4 2024 buy was Recursion Pharmaceuticals: 595,518 shares worth $4.03M.
  • Pivotal bioVenture Partners Investment Advisor added most to Vaxcyte in Q4 2024, an estimated $6.38M increase.
  • Pivotal bioVenture Partners Investment Advisor fully exited Exscientia Plc American Depositary Shares in Q4 2024, selling an estimated $3.76M.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 99% of its $148M portfolio in Q4 2024.
  • Pivotal bioVenture Partners Investment Advisor opened 1 new position and closed 1 in Q4 2024.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value fell 12% quarter-over-quarter to $148M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2024, filed 13 Feb 2025.